Clofazimine (CFZ) is an optically active, red-colored chemotherapeutic agent that is FDA approved for the treatment of leprosy and is on the World Health Organization's list of essential medications. Interestingly, CFZ massively accumulates in macrophages where it forms crystal-like drug inclusions (CLDIs) after oral administration of the drug in animals and humans. The analysis of the fluorescence spectra of CLDIs formed by resident tissue macrophages revealed that CFZ, when accumulated as CLDIs, undergoes a red shift in fluorescence excitation (from Ex: 540-570 to 560-600 nm) and emission (Em: 560-580 to 640-700 nm) signal relative to the soluble and free-base crystal forms of CFZ. Using epifluorescence microscopy, CLDI(1) cells could be identified, relative to CLDI(2) cells, based on a >3-fold increment in mean fluorescence signal at excitation 640 nm and emission at 670 nm. Similarly, CLDI(1) cells could be identified by flow cytometry, based on a >100-fold increment in mean fluorescence signal using excitation lasers at 640 nm and emission detectors >600 nm. CLDI's fluorescence excitation and emission was orthogonal to that of cell viability dyes such as propidium iodide and 4,6-diamidino-2-phenylindole dihydrochloride (DAPI), cellular staining dyes such as Hoechst 33342 (nucleus) and FM 1-43 (plasma membrane), as well as many other fluorescently tagged antibodies used for immunophenotyping analyses. In vivo, >85% of CLDI(1) cells in the peritoneal exudate were F4/80(1) macrophages and >97% of CLDI(1) cells in the alveolar exudate were CD11c(1). Most importantly, the viability of cells was minimally affected by the presence of CLDIs. Accordingly, these results establish that CFZ fluorescence in CLDIs is suitable for quantitative flow cytometric phenotyping analysis and functional studies of xenobiotic sequestering macrophages. V C 2015 International Society for Advancement of Cytometry
in macrophages, forming crystal-like drug inclusions (CLDIs) (2) (3) (4) (5) (6) (7) . After biochemical isolation, it is possible to analyze the composition of CLDIs, and we have elucidated that CLDIs are composed of domains of pure CFZ hydrochloride crystals (CFZ-HCl), bound and separated by membranes likely of cellular origin (8) .
Previously, bioaccumulation of uric acid crystals in macrophages and the phagocytosis of silica particles have been linked to the activation of proinflammatory signaling pathways in macrophages (9) (10) (11) (12) . Considering that CFZ possesses immunomodulatory activity (2, 13, 14) , we decided to determine whether CLDIs may elicit similar changes in macrophage function by developing a method by which CLDIcontaining macrophages could be isolated and functionally studied. As in solution, CFZ is weakly fluorescent and its fluorescence is pH sensitive as per the local microenvironment (5, 15) , we sought to determine whether the formation of CLDIs in macrophages is associated with specific shifts in the fluorescence excitation and emission spectra that could be used to detect CLDI-containing macrophages. Here, we report how CLDI formation leads to a far-red shift in CFZ's fluorescence signal, that is distinctively different from the fluorescence of soluble CFZ as well as free-base CFZ crystals (CFZ-TC). Additional experiments demonstrate how this far-red shift in fluorescence of CLDI-containing macrophages facilitates immunophenotyping and functional analysis of these xenobiotic sequestering cells.
MATERIALS AND METHODS

Animal Experiments
Mice (4-week old, male C57Bl6) were purchased from the Jackson Laboratory (Bar Harbor, ME) and acclimatized for 1 week in a specific pathogen-free animal facility. Animal care was provided by the University of Michigan's Unit for Laboratory Animal Medicine (ULAM) and the experimental protocol was approved by the Committee on Use and Care of Animals in accordance with NIH guidelines. An oral diet containing CFZ was fed to mice as described previously (2, 3, 8) . CFZ (C8895; Sigma-Aldrich, St. Louis, MO) was dissolved in sesame oil (Roland, China, or Shirakiku, Japan) to achieve a concentration of 3 mg/mL, which was mixed with Powdered Lab Diet 5001 (PMI International, St. Louis, MO) to produce a 0.03% drug to powdered feed mix. A corresponding amount of sesame oil was mixed with chow for vehicle treatment (control mice). On average, food consumption for a 25-g mouse was 3 g per day, resulting in 10 mg of bioavailable drug/kilogram per day. For CFZ treatment, the drug diet was administered for 8 weeks followed by regular chow for 8 weeks (washout phase).
Isolation of CLDIs from Mouse Spleen
At 8 weeks post-drug feeding, mice were euthanized by exsanguination while deeply anesthetized by an intraperitoneal injection of ketamine (100 mg/kg)/xylazine (10 mg/kg) and spleens were harvested and cut open to prepare tissue homogenate in phosphate-buffered saline (PBS). The tissue homogenate was sonicated for 30 min and centrifuged (100g for 1 min) to remove large cell debris. A solution of 10% sucrose in PBS was added to the acquired supernatant and the mixture was centrifuged (100g). The resulting supernatant was centrifuged (21,000g for 1 min) to pellet drug inclusions which were then resuspended in 2 mL of 10% sucrose. CLDIs were further purified using a three-layer discontinuous gradient (50, 30 , and 10% sucrose in PBS) centrifugation method (3,200g for 30 min, no brakes) (14) . The CFZ content of the isolated CLDIs was determined spectrophotometrically (k 5 495 nm) by procuring 100 lL of CLDIs (in triplicate) by centrifugation (21,000g for 1 min) and dissolution in DMSO followed by comparison with calibrated CFZ standards.
Fluorimetry
CFZ was dissolved in DMSO to achieve a concentration of 20 lM. Fluorescence excitation and emission scans were taken in increments of 10 nm from 400 to 800 nm on a Perkin-Elmer LS-55 fluorescence spectrometer using standard cuvettes. Data were imported into Microsoft V R Excel (Redmond, WA) (MS-Excel) for further analysis. The fluorescence yield was background subtracted using data obtained from solvent alone (DMSO) and was normalized to the maximum fluorescence yield measured across the spectral wavelength range tested.
Spectral Confocal Microscopy
For the preparation of slides, CFZ drug crystals were dusted on a glass slide followed by the application of a glass cover slip. For slides of CLDIs, a 20-lL drop of purified CLDIs was placed on a glass slide and allowed to dry overnight in the dark. The following day, a single drop of Prolong V R Gold (Life Technologies, Carlsbad, CA) was added to the CLDIs and a cover slip was applied prior to imaging. Spectral confocal microscopy was performed on a Leica Inverted SP5X confocal microscope system with two-photon FLIM (Leica Microsystems, Buffalo Grove, IL) using excitation wavelengths (k 5 470-670 nm). Image analysis and quantification was performed on Leica LAS AF. Several regions of interest of individual crystals were used to obtain fluorescence data which were imported into MS-Excel for further analysis. All fluorescence yields were normalized to the maximum fluorescence yield measured across the spectral range tested and background subtracted using data obtained from a blank slide.
Epifluorescence Microscopy
Visualization of all samples (cells or crystals) was done on a Nikon Eclipse Ti (Nikon Instruments, Melville, NY). The fluorescence filters (excitation/emission) used were optimized for 4,6-diamidino-2-phenylindole dihydrochloride (DAPI) (350/ 405 nm, exposure 5 50 ms), fluorescein isothiocyanate (FITC) (490/510 nm, exposure 5 100-500 ms), Texas Red (590/ 610 nm, exposure < 500 ms), and Cy5 (640/670 nm, exposure 5 15 ms). Brightfield color photographs were acquired using a Nikon DS-Fi2 camera, whereas fluorescence photographs were acquired using a Photometrics (14) . After 24 h post-CLDI incubation, cells were gently scraped and suspended in sterile flow cytometry tubes at a density of $2 3 10 6 cells/mL of PBS 1 5% FBS. The cells were analyzed on a MoFlo V R Astrios TM (Beckman Coulter, Brea, CA) using various laser combinations. Unless otherwise mentioned, forward and side scatter were measured using the 488-nm laser. Laser settings are referenced in the following format-excitation emission/bandwidth in nm. For example, if the excitation laser used is 488 nm and the emission detector is at 576 nm with a bandwidth of 21 nm, the written format is 488 576/21. To check the activity of viability dyes and signal compensation, just prior to analysis, propidium iodide (PI) (00-6990-50; Affymetrix eBioscience, San Diego, CA) or DAPI (D1306; Life Technologies, Grand Island, NY) was added to the cells (5 lL/1 3 10 6 cells). All gating and analysis was carried out on at least 10,000 cells (DAPI(2) or PI(2) cell population for viability studies) using FlowJo (FlowJo, LLC, Ashland, OR). MIFlowCytcompatible information for this experiment has been included in the Supporting Information Document (pages 5-11). Statistical analysis of sensitivity and specificity was conducted by acquiring >6 brightfield microscopy images of sorted cell populations on standard microscopy slides and >350 cells were counted for each sorting experiment. Sensitivity and specificity were calculated as follows. (16) . Mice were euthanized as described above followed by sterilization of the outer skin with 70% of ethanol. A small incision was made along the midline of the abdomen followed by abdominal skin retraction up to the thoracic boundary and the animal extremities to expose the intact peritoneal wall. A smaller incision was then made on the peritoneal wall to expose the cavity. The entire peritoneal cavity was washed with ice-cold sterile PBS 1 5% of FBS (5-10 mL) and collected as peritoneal exudate. The exudate was then centrifuged (100g for 5 min, 48C) and resuspended in 1.5 mL of PBS 1 5% of FBS. Cells were counted using a hemocytometer for viable cells using Trypan Blue and for CLDI-containing cells.
Sensitivity
Alveolar Lavage
Mice were euthanized as described above and the trachea was surgically exposed and cannulated with an 18G luer stub and the lungs were lavaged to obtain alveolar exudate by instilling calcium-and magnesium-free Dulbecco's PBS (DPBS) containing 0.5 mM of EDTA in 1 mL aliquots for a total of 6 mL. The alveolar exudate fluid was centrifuged (400g, 10 min, 48C) and resuspended in RPMI 1640 media. Viable (using Trypan Blue staining method) and CLDIcontaining cells were counted using a hemocytometer.
Flow Cytometry of Peritoneal and Alveolar Exudate
Peritoneal and alveolar lavage was performed as stated before to obtain the respective exudates. Purified Fc block CD16/32 (1 lL) was added for every 100,000 cells for analysis. For CLDI fluorescence signal experiments, cells were pelleted by centrifugation (100g for 5 min) followed by resuspension in PBS 1 5% of FBS (500 lL). For functional assays, antibodies-anti-F4/80-eFluor 450 (48-4801, Affymetrix eBioscience, San Diego, CA), anti-CD86-FITC (553691, BD Biosciences, San Jose, CA), anti-CD206-FITC (141704, BioLegend V R , San Diego, CA), anti-CD11c-eFluor450 (48-0114, Affymetrix eBioscience), and anti-Ly6G-eFluor450 (48-5931, Affymetrix eBioscience)-were added to the cell suspension at a loading of 1 lg/100,000 cells (volumetric ratio, 1:10) and incubated in the dark (30 min, 48C). After incubation, the samples were diluted with PBS and pelleted by centrifugation (100g, 5 min). The supernatant was discarded and the pellet was resuspended in 300 lL of PBS 1 2% of FBS. Just prior to analysis, PI (5 lL/ 1 3 10 6 cells) was added to the cells to assess viability. Sample measurements were carried out on a MoFlo V R Astrios TM EQ. All gating and analysis was done on at least 10,000 live cells (PI(2) cell population) using FlowJo. CLDI(1) cells were gated either using 640 671/30 or 640 795/70. A small subpopulation of CD206(1) cells, which was present in both CLDI(1) F4/80(2) and CLDI(2) F4/80(1) populations, exhibited high CD206 expression based on the intensity of the fluorescence signal. These cells also had extremely high side scatter that were measured as saturated signals. This small subpopulation of cells was not considered for the evaluation of change of CD206 expression in the peritoneal macrophages. MIFlowCyt-compatible information for this experiment has been included in the Supporting Information Document (pages [5] [6] [7] [8] [12] [13] [14] [15] [16] [17] .
Laser-Scanning Confocal Microscopy
CLDI-treated RAW264.7 cells were generated as mentioned above but on cover-slips in a six-well plate. The cells
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were washed with PBS buffer after which Hoechst 33342 (Invitrogen, Carlsbad, CA) and FM V R 1-43 (Molecular Probes T35356, Invitrogen) were used to stain cell nuclei and the plasma membrane, respectively. Cells were incubated with 1:1 v/v of dye mixtures of 5 lg/mL Hoechst 33342 and 7 lM FM V R 1-43 in HBSS (300 lL) for 15 min at room temperature. The confocal imaging of the live cells was performed on an Olympus Fluoview 500 (Olympus America, Center Valley, PA) using lasers for DAPI (405 450/50), FITC (488 525/50), and Cy5 (640 671/30) channels. Z-stack images of the cells were captured along the Z-axis (interval, 0.25 lm) and analyzed using the Nikon NIS-Elements 3.2 software (Nikon Instruments, Melville, NY). For peritoneal macrophages stained with F4/80, a drop of the stained cell sample was mounted on a blank microscopy slide; Prolong Gold and a cover-slip were applied followed by immediate scanning.
Data Plotting and Statistical Analysis
Plots were constructed using Origin 9.0 (OriginLab, Northampton, MA) and laid out in figure format using scalable vector graphics format (svg) in either Inkscape (www.inkscape.org) or GIMP (www.gimp.org). Flow cytometry plots were obtained in svg format directly from FlowJo and assembled using Inkscape. All statistical analysis was performed using Student's t-test in MS-Excel. Correlation statistics were done using a Pearson's test in Origin 9.0. The results were considered significant if P 0.05. MIFlowCyt compatible information was prepared using established standards (17) .
The completed MIFlowCyt checklist along with full gating strategies, machine information, and data analysis has been included in the Supporting Information Document. All original list mode files have been saved onto internal servers and can be obtained via email from the authors.
RESULTS
Fluorescence Spectral Analysis of CFZ and CLDIs
The fluorescence excitation and emission scan of CFZ dissolved in DMSO indicates that CFZ in solution is fluorescent in the range-excitation: 540-560 nm, emission: 560-600 nm (Fig. 1A) . To characterize the fluorescence of CFZ crystallized as a free-base triclinic crystal (closest triclinic polymorph of neutral CFZ crystal, CCDC refcode: DAK-XUI01), we used spectral confocal microscopy on individual CFZ-TC crystals dispersed on a microscopy slide. CFZ-TC has a similar fluorescence profile as soluble CFZ (Fig. 1B) . However, residual fluorescence of CFZ-TC is also detected at lower (Ex, 480-500 nm; Em, 510-540 nm) and higher (Ex, 580-600 nm; Em, 600-640 nm) spectral ranges. To characterize and identify a specific spectral signature associated with the intracellularly accumulated and crystallized CLDIs, the spleens of 8-week drug-fed mice were harvested and CLDIs were isolated and purified. By visual inspection, CLDIs were dark red, rod-shaped particles that were distinct from the orange-red CFZ-TC crystals (Figs. 1B and 1C, inset photographs). When subjected to fluorescence spectral analysis using the spectral , and (C) isolated CLDIs from spleen (bottom, representative picture, scale bar 5 10 lm) acquired using spectral confocal microscopy. The excitation wavelength (nm, Ex) and emission wavelength (nm, Em) are shown on the X-axis and Y-axis, respectively. The normalized fluorescence yield is shown by a contour plot that was normalized to the maximum measured fluorescence yield. Both solubilized CFZ in DMSO and CFZ-TC had peak fluorescence yield at Ex: 540-570 nm, Em: 560-580 nm, whereas CLDIs had peak fluorescence yield at Ex: 560-600 nm, Em: 640-700 nm. The excitation/emission combination for the detection of commonly used fluorophores: FITC, Cy3, Texas Red, 7-AAD, APC, and Cy5 is also shown as dotted bounded shapes superimposed on the contour plots. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.] confocal microscope, CLDIs exhibited a red-shift in their emission fluorescence spectra with peak fluorescence activity at Ex 5 560-600 nm, Em 5 650-690 nm (Fig. 1C) . To place this specific red-shift in the context of other commonly used dyes, CFZ-TC exhibited a fluorescence profile similar to FITC, Cyanine 3 (Cy3), Rhodamine, and Texas Red (TR), whereas CLDIs had a red-shifted fluorescence profile similar to TR, Cyanine 5 (Cy5), 7-Aminoactinomycin D, (7-AAD), Allophycocyanin (APC), and other commercial Cy5 derivatives.
Identification of CLDI-Containing Cell Subpopulations with Standard Flow Cytometer Configurations
To design a single-cell analysis technique to study the pharmacology of xenobiotic-sequestering macrophages and the impact of CLDIs on cellular functions, we proceeded to determine whether flow cytometery could be used to distinguish between cells that contain and do not contain CLDIs. The samples were analyzed using standard excitation lasers and detector configurations to determine the specific flow cytometry settings that can be used for analyzing CLDIcontaining cell subpopulations and to establish any spectral overlap (Fig. 2) . The use of ultraviolet (355 nm) and violet (405 nm) excitation lasers resulted in the detection of single populations at all emission detector settings, corresponding to the background autofluorescence signal of unlabeled cells. Similarly, a single-cell population was detected when the samples were excited with the blue (488 nm) or green (561 nm) excitation lasers at emission detection of <600 nm. However, Original Article at emission detection of >600 nm, two distinct cell populations were observed, one which corresponded to the background fluorescence signal of CLDI-free cells (labeled 1), and the other which corresponded to the positive fluorescence signal of the CLDI-containing cells (labeled 2). Furthermore, the use of the red (592 nm) and far-red (640 nm) excitation laser resulted in the detection of two cell subpopulations corresponding to the CLDI-free and CLDI-containing cells, at all tested emission detector settings. The laser and detector settings that detected the subpopulation of CLDI-containing cells corresponded to the CLDI fluorescence spectra, which were independently measured using the spectral confocal microscope (Fig. 1C) .
To confirm these observations, a fluorescence-activated cell sorting experiment was performed using 488 664/22, 561 692/75, and 640 671/30 [See italicized statement in Methods and Supporting Information containing MIFlowCyt information on description of laser settings] along with laser-scanning confocal microscopy of incubated cells. When RAW264.7 cells incubated with CLDIs and labeled with fluorescent cellular staining dyes-Hoechst 33342 (nucleus) and FM 1-43 (plasma membrane) were imaged, the intracellular accumulation of CLDIs was confirmed via their far-red fluorescence (Fig. 2,  bottom) distinct from the green fluorescence of FM 1-43 and blue fluorescence of Hoechst 33342. Additionally, as per brightfield microscopy, the sorted cell population with the lower fluorescence signal corresponded to CLDI-free cells, whereas the sorted cell population within the high fluorescence signal corresponded to CLDI-containing cells (Fig. 3A) . The sorting sensitivity was 98.34, 98.82, and 99.01% at 488 664/22, 561 692/75, and 640 671/30, respectively, whereas sorting specificity was 86.30, 90.80, and 93.98%, respectively (for formula, see Materials and Methods section). The detection of CLDIs in subsequent flow cytometry experiments was done using either 640 671/30 or 640 795/70, whereas for microscopy, CLDIs were detected using the red laser (excitation, 640 nm; emission, 670 nm).
Functional Flow Cytometric Analysis of Live Versus Dead, CLDI-Containing Cells
In flow cytometry experiments, a fundamental functional assay involves discriminating live and dead cells using standard fluorescent labels. Accordingly, to determine whether CLDI-containing cells were viable, RAW264.7 cells loaded with CLDIs were further incubated with membrane impermeant cell viability dyes-PI or DAPI prior to flow cytometric analysis. Using the laser-detector settings for PI-561 614/20, two populations were detected using CLDI-incubated RAW264.7 cells. We conducted a compensation of the spectral overlap that was observed at 561 614/20 to verify that PI can be used in the presence of CLDIs (at 640 671/30) without signal overlap (Fig. 3B) . Incubating control (CLDI free) cells with PI yielded two distinct cell populations, corresponding to live (low fluorescence signal) and dead (high fluorescence signal) cells (Fig. 3B) . In contrast, after CLDI-containing cell samples were incubated with PI, four populations were observed, corresponding to viable CLDI-free (Live CLDI(2)) and viable CLDI-containing cells (Live CLDI(1)), and dead CLDI-free (Dead CLDI(2)), and dead CLDI-containing cells ((Dead CLDI(1)) (Fig. 3B, Supporting Information Fig. S2 ). In the same manner, flow cytometric analysis revealed that DAPI could be used to determine the viability of cells containing CLDIs (Fig. 3C) . With DAPI, four distinct populations were observed (without compensation), corresponding to live (weak signal) and dead (strong signal), CLDI containing (marked as CLDI (1)) and CLDI-free (marked as CLDI (2)) cells. Thus, both PI and DAPI were suitable as fluorescent markers for discriminating between live and dead cell subpopulations of CLDI-containing cells.
In Vivo Flow Cytometry Detection of CLDI-Containing Cells in Peritoneal and Alveolar Exudates from CFZTreated Mice
To measure the presence of CLDIs in peritoneal exudates obtained from CFZ-treated mice, we performed a quantitative, flow cytometric analysis on peritoneal exudate of mice after 8-week drug administration. The control mouse peritoneal exudate showed two distinct populations (Fig. 4A, labeled  1 and 2) at all tested laser settings while the CFZ mouse peritoneal exudate showed two populations when assayed with the 405 448/59 or 488 513/26 laser-detector combination. With the use of 532 576/21, 592 620/29, 640 671/30, and 640 795/70, however, three distinct populations were observed (Fig. 4A, labeled 1-3) . The mean fluorescence intensity of Population 3 was increased >100-fold relative to Population 1 at 640 671/30 and 640 795/70. To confirm that the third population was CLDI(1) cells, we sorted the cell populations labeled 1 and 3 using the 640 795/70 laser-detector combination and plated them in cell culture media overnight. Population 1 was confirmed to be CLDI(2) cells, whereas Population 3 was indeed CLDI(1) cells (Fig. 4B) .
Next, we proceeded to determine whether the time course of CLDI accumulation in macrophages as determined by flow cytometry corresponded to the expected time course of CLDI accumulation after drug treatment (2,3). After drug treatment of mice for varying time periods, peritoneal exudates were obtained and analyzed by flow cytometry as well as light microscopy, revealing that CLDIs were not present at 1 and 2 weeks, but could be detected starting at 4 weeks (Fig. 4C) .
To determine whether flow cytometry could be used to characterize the molecular phenotype of CLDI-containing macrophage subpopulations, multistain flow cytometry was conducted on peritoneal exudates of CFZ-treated animals. For this purpose, cells obtained from peritoneal exudates were incubated with other commonly employed macrophage-targeted antibodies possessing fluorescent signals distinct from that of CLDIs (405 448/59 and 488 513/26; Fig. 1 ). As CLDI accumulation has been reported to be macrophage targeted (3, (18) (19) (20) , we chose the murine pan-macrophage marker F4/80 as well as other macrophage phenotype surface markers-CD86 and CD206 (Fig.  5) . The schematic representation for the quantification of the gating strategy is shown in Figures 5A and 5B and Supporting Information Figure S1 . The analysis revealed that in peritoneal exudates, CLDIs were primarily localized to F4/80(1) peritoneal macrophages (PMU) (>85% of total CLDI(1) cells at all measured time points, Fig. 5B , no statistically significant changes across the times measured). This observation was also confirmed via laser-scanning confocal microscopy using the farred fluorescence region for CLDIs and the violet laser to visualize F4/80 extracellular membrane staining (Fig. 5B) . The accumulation, however, was both treatment and time dependent with respect to F4/80(1) PMU as $38% of F4/80(1) PMU were CLDI(1) after 4 weeks of CFZ treatment which increased to $61% after 8 weeks (P < 0.05) of treatment and declined to $25% at 8 weeks of washout (P < 0.05; Fig. 5C(i) ). Within F4/ 80(1) CD86 (1) cells, CLDI accumulation increased in a timedependent fashion, from $31% after 4 weeks of CFZ treatment to $95% at 8 weeks 1 8 weeks washout (P < 0.05, Fig. 5C(ii) ). As a proportion of F4/80(1) CD206(1) cells, CLDI(1)% increased from $15% after 4 weeks of CFZ treatment to $93% after 8 weeks 1 8 weeks washout (P < 0.05, Fig. 5C(iii) ). Collectively, these findings suggest that CLDI accumulation was not restricted to the CD86(1) or CD206(1) macrophage phenotype (Fig. 5B) . In a related trend, % CLDI(1) cells that could be identified as F4/80(1) CD86(1) increased from $38% at 4 weeks post-drug feeding to $70% at 8 weeks 1 8 weeks washout (P < 0.05), whereas % CLDI(1) cells that could be identified as F4/80(1) CD206(1) increased from $20% at 4 weeks post-drug feeding to $81% at 8 weeks 1 8 weeks washout (P < 0.05). Although the accumulation of CLDIs in CD86(1) cells was higher relative to CD206(1) cells at 4-and 8-week post-drug feeding (P < 0.05), the accumulation was not statistically deviated toward any phenotype at 8 weeks 1 8 weeks washout (P > 0.05). In contrast, the ratiometric CD86 median surface expression in CLDI(1) relative to CLDI(2) decreased from $1.17 at 4-week post-drug feeding to 0.95 (P < 0.05, Fig. 5C(iv) ) at 8-week post-drug feeding. The ratiometric CD206 median surface expression in CLDI(1) relative to CLDI(2) CD206 remained between $0.97 and $1.15 for CD206 with no statistically significant difference at the three measured time points (Fig. 5C(iv) ). As the fold change in the median surface expression is much less than the benchmark of twofold change in expression to ascertain significant change in the expression of the two surface markers-the changes, as a result of being CLDI(1), reflect relatively minor expressional differences between the two populations. Finally, the viability of F4/80(1) cells, as measured via PI(2) cells, was unaffected by the presence of CLDIs (viability of CLDI(1) F4/ 80(1) 5 87 6 6%, CLDI(2) F4/80(1) 5 88 6 12%, P 5 0.84 between the two groups, n 5 4). The viability measured via flow cytometry also agreed with the sample viability of CLDI1 cells in the peritoneal exudate measured by Trypan blue staining (87 6 9%, n 5 4).
To follow up our analysis on peritoneal exudate, we performed a flow cytometric analysis on alveolar exudate of drug-fed mice at 8 weeks to confirm the macrophage-specific accumulation of CLDIs in the lung (2, 4, 18) (Fig. 6 ). Both the control and the CFZ mice alveolar exudates had two distinct populations. However, Population 2, that had high side scatter, had a distinctly higher fluorescence at the settings used to Original Article detect CLDIs (640 671/30), marking them out as CLDI (1) cells. Upon further testing with fluorescent antibodies (at 405 448/59), specific for alveolar macrophages (CD11c) and neutrophils (Ly6G) (21) , CLDI(1) cells were determined to be overwhelmingly CD11c(1) (>99%), whereas <2% of Ly6G(1) cells were detected as CLDI(1). 
Correlation of CLDI Amount with Mean Cellular Fluorescence Intensity
In fluorescence activated cell sorting experiments, attempts to relate the mean cellular fluorescence intensity (MFI) of sorted cell populations with the total number of CLDIs per cell did not yield interpretable data. Therefore, to determine whether the fluorescence signal per cell was related to the number of CLDIs in each cell, we incubated RAW264.7 macrophage cells with CLDIs, and acquired fluorescence images with conventional epifluorescence microscopy using the Cy5 filter for CLDIs (Supporting Information Fig. S3 ). The normalized background-corrected MFI of cells were Original Article strongly correlated (Pearson's r 5 0.70, P < 0.0001) with the number of CLDIs/cell. As expected, cell MFI was uncorrelated to intracellular CLDI geometry and morphology (Supporting Information Fig. S4 , Pearson's r 5 20.2 to 0.3, P < 0.005). The resulting fluorescence signal readily distinguished CLDI(1) cell relative to a CLDI(2) cells (P < 0.005, Supporting Information Table S1 ). Cells containing 1 versus 2 CLDIs were also distinguishable (P < 0.05). However, cells containing >2 CLDIs could not be distinguished from cells containing fewer CLDIs. Given that each CLDI contains $25 fmol of CFZ (24.3 6 13.5, n 5 8 mice), we infer that this method could be used to quantify CFZ sequestration in CLDIs, up to 50 fmol of CFZ (corresponding to two CLDIs per cell).
DISCUSSION
The pharmacological activity of CFZ, its pharmacokinetics, and its effectiveness as an antimycobacterial agent have been intensively studied for several decades (1, (22) (23) (24) (25) (26) (27) (28) . Remarkably, the optical properties of CFZ have been largely unrecognized, especially in the context of its intracellular bioaccumulation behavior. Although CFZ's accumulation in CLDIs has been clinically observed, the phenotypic characteristics and the mechanisms that underlie such massive intracellular bioaccumulation have not been studied (2, 7, 18, 19, 26, 29) . Seeking to understand whether the intracellular bioaccumulation of CFZ affects the optical properties of the drug, we determined whether there are spectral shifts in fluorescence excitation and the emission spectrum of CLDIs in relation to the soluble form of the drug. As a reference, CFZ was readily crystallized as a free base-CFZ-TC (CCDC ref code: DAKXUI01) and the spectrum of the CFZ-TC crystals was analyzed and compared to that of CLDIs. Using a spectral confocal microscope imaging system, fluorescence spectral analysis was carried out on CLDIs, and compared to the fluorescence spectra of pure crystalline forms of CFZ, resulting in a red shift in the fluorescence emission spectra in CLDIs. This fluorescence shift led to a highly specific signal that was largely confined to channels that are used to detect far-red probes such as Cyanine 5-like fluorescence either in Cyanine 5 (Cy5) or its various commercial conjugates in standard epifluorescence microscopes filter setups and flow cytometers. Surprisingly, although CFZ and CFZ-TC have strong fluorescence in the green to midred fluorescence range, CLDIs exhibited a pronounced, redshifted fluorescence emission profile, spanning the red to far-red range of the visible spectrum. Unlike CLDIs, both CFZ and CFZ-TC exhibited some fluorescence in the blue-green wavelengths of the electromagnetic spectrum.
To assess the utility of the far-red fluorescence activity of CLDIs, we proceeded to detect the fluorescence signal with a flow cytometry approach using different lasers on a macrophage-derived cell line that is known to internalize CLDIs through phagocytosis. Inside cells, the fluorescence of CLDIs Figure 6 . Flow cytometric analysis of alveolar exudate at 8-weeks post-drug feeding. PI fluorescence was detected using the compensated 561 614/20 laser-detector setting whereas CLDI fluorescence was detected using the 640,671/30 setting. Gating was done on live cells followed by CLDI(1) cells. The population labeled 2 in orange color showed significant CLDI signal marking them out as CLDI (1) cells. The alveolar exudate was also labeled with antibodies for the macrophage surface marker CD11c (detected using 405 448/59) or the neutrophil surface marker Ly6G (detected using 405 448/59). CLDI(1) cells were overwhelmingly CD11c(1) (>99%, six pooled mice lavage sample, repeated twice) and Ly6G(2) (six pooled mice lavage sample, repeated twice). Gating for antibody positivity was done using the corresponding isotype (gray background histogram). [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary. com.] was specific to the red and far-red fluorescence spectral channels, corresponding to the fluorescence spectra obtained with the spectral confocal microscope. The accuracy and sensitivity of the flow cytometer for detecting CLDI(1) cells from a mixed population of cells was calculated to be >98% sensitive and >93% specific. Owing to minimal spectral overlap in the ultraviolet, violet, blue, and green fluorescence channels, CLDIs can be readily used as a marker for xenobiotic sequestering macrophages, for multicolor flow cytometric analysis with orthogonal fluorescent probes and cellular staining dyes for microscopic analysis and image cytometry (30) .
Proceeding to analyze the phenotypic characteristics of xenobiotic sequestering PMU and alveolar macrophages (AMU) that bioaccumulate CFZ upon prolonged oral feeding in mice, we confirmed that the laser detector combination of 640 671/30 or 640 795/70 could be used to identify CLDI(1) cells. Three populations were observed (Fig. 4) with the peritoneal exudate. Populations 1 and 2 were of high side scatter and low side scatter, respectively, but had low fluorescence. Earlier reports have characterized that peritoneal exudates contain primarily PMU and B cells (16, 31) . Based on the scatter analysis, Population 1 was most likely PMU, whereas Population 2 contained B cells. Population 3 had high side scatter as well as high fluorescence, indicating that they were CLDI(1) cells as well as most likely a PMU cell population. This was confirmed by sorting the fluorescent and nonfluorescent cell populations, plating the corresponding populations on tissue culture dishes, and visually inspecting them for the presence or absence of CLDIs. In the alveolar exudate, two distinct populations were observed for both control and CFZ mice samples. The high side-scatter population was identified to contain CLDIs owing to the high-fluorescence signal detected with that population in the CFZ mice samples, identifying it as a potential AMU population as well.
Murine resident PMU as well as macrophages of others organs have high F4/80 plasma membrane expression (32) . F4/80 is encoded by the gene Emr1, a member of the adhesion-GPCR family of proteins that play notable roles in immune modulation and related functions (33) (www.genecards.org). Based on the expression of other surface markers, these macrophages can be classified into two specific functional categories-classically activated macrophages (M1) and alternatively activated macrophages (M2) (12, (34) (35) (36) (37) (38) . M1 macrophages noticeably express high levels of the cell-surface marker CD86 that is critical for host defense but can also be harmful to the host (36, 37) . M2 macrophages express high levels of CD206 and are key mediators of host inflammation via the their wound healing, tissue remodeling, and angiogenic functions (34, 35) . Most importantly, both CD86 and CD206 are exclusive to M1 and M2 type macrophages, respectively, serving as important biomarkers for inflammationrelated events. With the use of the CLDI-specific signal, we confirmed that the majority of the CLDI(1) cells were indeed F4/801 PMU (>85%) and the presence of CLDIs had a minor effect on polarizing the macrophages toward the M2 phenotype (34) .
Analyzing the alveolar exudate, CLDI accumulation was specifically targeted toward CD11c(1) cells (>99%), whereas Ly6G(1) cells had negligibly low CLDI accumulation. Alveolar exudates from healthy humans (39) and mice (40) typically contain AMU, neutrophils, and lymphocytes. CD11c is an integrin protein, encoded by the gene ITGAX, with useful functions in cell-cell interactions during inflammation as well as in macrophage adhesion and chemotaxis (www.genecards. org). CD11c is also an important surface cell marker for evaluating murine AMU (CD11c(1)) (21,41,42 ). Ly6G is a murine glycosylphosphatidylinositol-anchored protein with unknown functions in cellular physiology (43) . It is also a neutrophilspecific surface marker that has been used to examine inflammation models in various tissues (21, 44, 45) . Using these specific immune markers for macrophages and neutrophils, CLDI accumulation was confirmed to be mostly present in AMU.
Like other fluorescent probes that emit in the far-red or infrared regions of the electromagnetic spectrum (46, 47) , the intrinsic fluorescence of CLDIs exhibits favorable optical properties (47) , with minimal background fluorescence in the far-red and near infra-red region allowing accurate quantitative analysis with the flow cytometer or fluorescence microscope (48) . Accordingly, these results demonstrate that CFZ, when stabilized as CLDIs, has excellent properties as a fluorescent probe for characterizing the specific macrophage subpopulations involved in xenobiotic disposition. As with other fluorescence-based measurement method, this fluorescence signal was saturatable, although there was a significant correlation between the fluorescence signal of the cells and the number of CLDIs per cell for cells containing 0, 1, or 2 CLDIs, the correlation was lost for cells containing three or more CLDIs. Nevertheless, the specific fluorescence signal of CLDIs could serve as an all-or-none probe for detecting and sorting xenobiotic sequestering macrophages, and as a tracking probe to follow the function of these cells during inflammation and wound healing. Considering that recent studies have pointed out the therapeutic efficacy of CFZ for drug-resistant tuberculosis, the potential application of CLDIs as cellular-targeted probes for the assessment of antimycobacterial activity is promising (49) (50) (51) (52) (53) (54) . In terms of the functional significance of these xenobiotic sequestering macrophages, other poorly soluble drugs, endogenous metabolites, and toxins have been reported to bioaccumulate within macrophages. Such bioaccumulating agents are often associated with a macrophage activation phenotype, favoring the M1 population which was not observed in the case of the CLDI-containing cells (9) (10) (11) (12) . Using a fluorescence-activated cell sorter, the isolation of CLDI(1) cell subpopulations will enable a precisely quantified approach toward understanding the mechanisms of xenobiotic sequestration.
CONCLUSIONS
In summary, the analysis of macrophage populations in vitro and ex vivo was made possible owing to the unique fluorescence spectral characteristics of CLDIs relative to neutral Original Article free base CFZ precipitates as well as the CFZ molecule in soluble form. The specific fluorescence of CLDIs was utilized in single-cell flow cytometry to study macrophage-related intracellular drug accumulation wherein we were able to measure macrophage functions including viability and expression of different cell surface markers, by exploiting the unique fluorescence spectrum of CLDIs and the availability of many other orthogonal fluorescent probes that can be detected with standard flow cytometry parameters, with minimal spectral overlap from the CLDI signal. We also confirmed that the presence of CLDIs has a minor polarizing effect toward the M2 macrophage phenotype. More importantly, the unique fluorescence shift of CFZ molecules from the freely soluble green-blue fluorescent state to the solid far-red CLDI fluorescent state should facilitate analysis of the molecular mechanisms driving drug accumulation and CLDI formation, using a variety of molecular, pharmacological, genetic, or systems biology approaches. These studies will be instrumental for furthering the understanding of the role of xenobiotic sequestering macrophages of the organism in response to bioaccumulating drugs or environmental toxicants. 
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